Beyond the weight-loss supercycle, a new class of targeted therapies is driving institutional rotation into mid-cap biotech...
Business
The AI infrastructure buildout has a bottleneck — and MU owns it.
NVDA beat hard, guided higher, and still slipped. The market's reaction might be the most important signal...
Everyone is chasing the chip trade. The real bottleneck -- and the real opportunity -- is the...
A landmark CHIPS Act deal and a commercial hardware breakthrough are changing the conversation around this volatile...
Record revenue. Record guidance. And the stock still drifted lower. Here's what that tells options traders right...
